Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or Stomach
Status:
Completed
Trial end date:
2004-08-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of combining docetaxel and irinotecan in
treating patients who have advanced cancer of the esophagus or stomach.